+ Filter
Loading...
WNV-DIII
Loading...Anti-WNV-DIII Products
- Recombinant Anti-WNV-DIII Antibody (MOB-1051)
-
- Derivation: Mouse
- Species Reactivity: WNV
- Type: IgG
- Application: ELISA, WB, FuncS
Compare
- Recombinant Human Anti-WNV-DIII Antibody (MHH-1051)
-
- Derivation: Human
- Species Reactivity: WNV
- Type: IgG
- Application: Neut, WB, FuncS
Compare
- Recombinant Human Anti-WNV-DIII Antibody Fab Fragment (MHH-1051-F(E))
-
- Derivation: Human
- Species Reactivity: WNV
- Type: Fab
- Application: RIA, IF, FuncS
Compare
- Recombinant Human Anti-WNV-DIII Antibody scFv Fragment (MHH-1051-S(P))
-
- Derivation: Human
- Species Reactivity: WNV
- Type: scFv
- Application: WB, IF, FuncS
Compare
- Recombinant Anti-WNV-DIII Antibody Fab Fragment (MOB-1051-F(E))
-
- Derivation: Mouse
- Species Reactivity: WNV
- Type: Fab
- Application: FC, IP, FuncS
Compare
- Recombinant Anti-WNV-DIII Antibody scFv Fragment (MOB-1051-S(P))
-
- Derivation: Mouse
- Species Reactivity: WNV
- Type: scFv
- Application: IF, FC, Biosensors, FuncS
Compare
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
The involvement of domain III of West Nile virus (WNV-DIII) envelope protein in binding to host cell surface was investigated. WNV-DIII was first expressed as a recombinant protein and purified after a solubilization and refolding procedure. The refolded WNV-DIII protein displays a content of betasheets consistent with known homologous structures of other flavivirus envelope DIII, shown by using circular dichroism analysis. Purified recombinant WNV-DIII protein was able to inhibit WNV entry into Vero cells and C6/36 mosquito cells. Recombinant WNV-DIII only partially blocked the entry of dengue-2 (Den 2) virus into Vero cells. However, entry of Den 2 virus into C6/36 was blocked effectively by recombinant WNV-DIII. Murine polyclonal serum produced against recombinant WNV-DIII protein inhibited infection with WNV and to a much lesser extent with Den 2 virus, as demonstrated by plaque neutralization assays.